PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsAcurx Pharmaceuticals
Acurx Pharmaceuticals(ACXP)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Bevifimod
healthy volunteers/patients
,
gastrointestinal neoplasms
,
follicular lymphoma
,
carcinoma
,
pancreatic neoplasms
,
neoplasm metastasis
,
respiratory tract diseases
,
pleural effusion
,
lung diseases
,
respiratory tract neoplasms
,
bronchogenic carcinoma
,
thoracic neoplasms
,
neoplasms by site
,
malignant pleural effusion
,
pleural diseases
,
pleural neoplasms
,
myeloid leukemia acute
,
neoplasms
,
squamous cell carcinoma of head and neck
,
head and neck neoplasms
,
recurrence
,
squamous cell carcinoma
,
squamous cell neoplasms
,
multiple myeloma
,
chronic hepatitis c
,
abdominal pain
,
asthma
,
adenocarcinoma of lung
,
non-small-cell lung carcinoma
,
type 2 diabetes mellitus
,
psoriasis
,
colorectal neoplasms
,
diabetes mellitus
,
lung neoplasms
,
non-hodgkin lymphoma
,
adenocarcinoma
,
breast neoplasms
,
crohn disease
,
stroke
,
ischemic stroke
,
pulmonary embolism
,
skin diseases
,
papulosquamous skin diseases
,
essential hypertension
,
restless legs syndrome
,
hyperglycemia
,
rheumatoid arthritis
,
respiratory distress syndrome
,
vascular access devices
,
catheter obstruction
,
heart arrest
,
ischemia
,
type 1 diabetes mellitus
,
embolism
,
polycystic kidney diseases
,
hypertension
,
myocardial infarction
,
infarction
,
hiv infections
,
kidney diseases
,
diabetic neuropathies
,
diabetic nephropathies
,
fibrosis
,
idiopathic pulmonary fibrosis
,
pulmonary fibrosis
,
liver cirrhosis
,
parkinson disease
,
peripheral arterial disease
,
intermittent claudication
,
peripheral vascular diseases
,
pneumonia
,
disease progression
,
hypersensitivity
,
extrinsic allergic alveolitis
IBEZAPOLSTAT
clostridium infections
,
recurrence
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use